Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eyepoint Pharmaceuticals, Inc. (EYPT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Eyepoint Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1314102.
Total stock buying since 2015: $130,818,517.
Total stock sales since 2015: $130,015,976.
Total stock option exercises since 2015: $3,205,411.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 10,000 | $58,999 | 0 | $0 | 248,992 | $0 |
2024 | 2,310,005 | $38,084,127 | 4,041,666 | $79,378,111 | 502,281 | $1,690,715 |
2023 | 2,507,292 | $61,465,265 | 2,777,084 | $49,558,582 | 174,400 | $892,900 |
2022 | 1,000 | $12,210 | 0 | $0 | 57,401 | $0 |
2021 | 0 | $0 | 10,000 | $201,480 | 45,564 | $0 |
2020 | 128,000 | $124,586 | 0 | $0 | 453,141 | $0 |
2019 | 100,500 | $173,369 | 0 | $0 | 237,898 | $144,849 |
2018 | 25,470,390 | $30,799,999 | 0 | $0 | 407,058 | $248,599 |
2017 | 56,700 | $99,962 | 0 | $0 | 0 | $0 |
2016 | 0 | $0 | 5,000 | $23,500 | 15,000 | $20,349 |
2015 | 0 | $0 | 160,000 | $854,303 | 160,000 | $207,999 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-07 | 0 | $0 | 0 | $0 | 29,778 | $0 |
2025-05 | 10,000 | $58,999 | 0 | $0 | 7,500 | $0 |
2025-02 | 0 | $0 | 0 | $0 | 32,834 | $0 |
2025-01 | 0 | $0 | 0 | $0 | 178,880 | $0 |
2024-08 | 23,240 | $184,499 | 0 | $0 | 0 | $0 |
2024-07 | 0 | $0 | 11,625 | $116,994 | 39,552 | $33,039 |
2024-06 | 0 | $0 | 0 | $0 | 2,000 | $0 |
2024-05 | 850,000 | $10,225,500 | 11,625 | $147,044 | 9,775 | $33,039 |
2024-04 | 581,765 | $10,623,028 | 0 | $0 | 0 | $0 |
2024-03 | 0 | $0 | 0 | $0 | 50,404 | $0 |
2024-02 | 0 | $0 | 209 | $5,954 | 81,277 | $2,397 |
2024-01 | 855,000 | $17,051,100 | 4,018,207 | $79,108,119 | 319,273 | $1,622,240 |
2023-12 | 2,507,292 | $61,465,265 | 2,097,083 | $41,129,382 | 77,083 | $892,900 |
2023-08 | 0 | $0 | 680,000 | $8,429,194 | 0 | $0 |
2023-07 | 0 | $0 | 0 | $0 | 2,000 | $0 |
2023-06 | 0 | $0 | 0 | $0 | 2,000 | $0 |
2023-05 | 0 | $0 | 1 | $6 | 0 | $0 |
2023-02 | 0 | $0 | 0 | $0 | 93,317 | $0 |
2022-11 | 0 | $0 | 0 | $0 | 15,258 | $0 |
2022-03 | 1,000 | $12,210 | 0 | $0 | 0 | $0 |
2022-02 | 0 | $0 | 0 | $0 | 42,143 | $0 |
2021-11 | 0 | $0 | 10,000 | $201,480 | 0 | $0 |
2021-06 | 0 | $0 | 0 | $0 | 1,420 | $0 |
2021-02 | 0 | $0 | 0 | $0 | 44,144 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-07-11 | Zaderej Karen L. | Option Ex | 2,000 | .00 | 0 |
2025-07-10 | Duker Jay S. (President and CEO) | Option Ex | 16,667 | .00 | 0 |
2025-07-10 | Lurker Nancy | Option Ex | 11,111 | .00 | 0 |
2025-05-25 | Elston George (Chief Financial Officer) | Option Ex | 7,500 | .00 | 0 |
2025-05-19 | Zaderej Karen L. | Buy | 5,000 | 5.99 | 29,950 |
2025-05-16 | Zaderej Karen L. | Buy | 5,000 | 5.81 | 29,049 |
2025-02-09 | Duker Jay S. (President and CEO) | Option Ex | 7,000 | .00 | 0 |
2025-02-09 | Lurker Nancy | Option Ex | 20,000 | .00 | 0 |
2025-02-09 | Elston George (Chief Financial Officer) | Option Ex | 5,834 | .00 | 0 |
2025-01-06 | Duker Jay S. (President and CEO) | Option Ex | 20,794 | .00 | 0 |
2025-01-06 | Lurker Nancy | Option Ex | 75,134 | .00 | 0 |
2025-01-06 | Elston George (Chief Financial Officer) | Option Ex | 15,285 | .00 | 0 |
2025-01-05 | Duker Jay S. (President and CEO) | Option Ex | 30,000 | .00 | 0 |
2025-01-05 | Landis John B. | Option Ex | 10,000 | .00 | 0 |
2025-01-05 | Lurker Nancy | Option Ex | 12,667 | .00 | 0 |
2025-01-05 | Elston George (Chief Financial Officer) | Option Ex | 15,000 | .00 | 0 |
2024-08-21 | Ando Goran | Buy | 5,000 | 7.95 | 39,750 |
2024-08-20 | Dicicco Wendy F | Buy | 2,567 | 7.79 | 19,996 |
2024-08-19 | Zaderej Karen L. | Buy | 12,500 | 7.98 | 99,750 |
2024-08-16 | Lurker Nancy | Buy | 3,173 | 7.88 | 25,003 |
2024-07-12 | Guyer David R | Sale | 11,625 | 10.06 | 116,994 |
2024-07-12 | Guyer David R | Option Ex | 9,775 | 3.38 | 33,039 |
2024-07-11 | Zaderej Karen L. | Option Ex | 2,000 | .00 | 0 |
2024-07-10 | Duker Jay S. (President and CEO) | Option Ex | 16,666 | .00 | 0 |
2024-07-10 | Lurker Nancy (Executive Vice Chair) | Option Ex | 11,111 | .00 | 0 |
2024-06-23 | Adamis Anthony P | Option Ex | 2,000 | .00 | 0 |
2024-05-14 | Guyer David R | Sale | 11,625 | 12.65 | 147,044 |
2024-05-14 | Guyer David R | Option Ex | 9,775 | 3.38 | 33,039 |
2024-05-06 | Cormorant Global Healthcare Master Fund, Lp | Buy | 850,000 | 12.03 | 10,225,500 |
2024-04-18 | Cormorant Global Healthcare Master Fund, Lp | Buy | 581,765 | 18.26 | 10,623,028 |
2024-03-30 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 50,404 | .00 | 0 |
2024-02-09 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 9,967 | .00 | 0 |
2024-02-09 | Duker Jay S. (President and CEO) | Option Ex | 11,967 | .00 | 0 |
2024-02-09 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 10,800 | .00 | 0 |
2024-02-09 | Lurker Nancy (Executive Vice Chair) | Option Ex | 37,534 | .00 | 0 |
2024-02-09 | Elston George (Chief Financial Officer) | Option Ex | 10,800 | .00 | 0 |
2024-02-02 | Jones David Scott (SVP & Chief Commercial Officer) | Sale | 209 | 28.49 | 5,954 |
2024-02-02 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 209 | 11.47 | 2,397 |
2024-01-26 | Jones David Scott (SVP & Chief Commercial Officer) | Sale | 26,017 | 25.36 | 659,791 |
2024-01-26 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 26,017 | 8.08 | 210,217 |
2024-01-26 | Paggiarino Dario A. (Chief Medical Officer) | Sale | 49,325 | 25.53 | 1,259,217 |
2024-01-26 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 49,325 | 13.05 | 643,839 |
2024-01-25 | Jones David Scott (SVP & Chief Commercial Officer) | Sale | 600 | 25.00 | 15,000 |
2024-01-25 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 600 | 8.08 | 4,848 |
2024-01-25 | Paggiarino Dario A. (Chief Medical Officer) | Sale | 600 | 25.00 | 15,000 |
2024-01-25 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 600 | 13.02 | 7,809 |
2024-01-24 | Jones David Scott (SVP & Chief Commercial Officer) | Sale | 11,300 | 25.01 | 282,624 |
2024-01-24 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 11,300 | 8.08 | 91,304 |
2024-01-24 | Paggiarino Dario A. (Chief Medical Officer) | Sale | 11,251 | 25.01 | 281,410 |
2024-01-24 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 11,251 | 13.02 | 146,431 |
2024-01-24 | Lurker Nancy (Executive Vice Chair) | Sale | 29,956 | 24.98 | 748,240 |
2024-01-23 | Jones David Scott (SVP & Chief Commercial Officer) | Sale | 900 | 25.00 | 22,500 |
2024-01-23 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 900 | 8.08 | 7,272 |
2024-01-23 | Paggiarino Dario A. (Chief Medical Officer) | Sale | 5,135 | 25.00 | 128,375 |
2024-01-23 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 5,135 | 13.02 | 66,832 |
2024-01-23 | Lurker Nancy (Executive Vice Chair) | Sale | 5,044 | 24.97 | 125,948 |
2024-01-22 | Jones David Scott (SVP & Chief Commercial Officer) | Sale | 34,166 | 22.46 | 767,436 |
2024-01-22 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 34,166 | 10.80 | 368,992 |
2024-01-11 | Liu Ye | Sale | 1,910,500 | 19.45 | 37,159,225 |
2024-01-11 | Ocumension Therapeutics (Director) | Sale | 1,910,500 | 19.45 | 37,159,225 |
2024-01-11 | Cormorant Global Healthcare Master Fund, Lp | Buy | 750,000 | 19.75 | 14,812,500 |
2024-01-09 | Cormorant Global Healthcare Master Fund, Lp | Buy | 105,000 | 21.32 | 2,238,600 |
2024-01-08 | Paggiarino Dario A. (Chief Medical Officer) | Sale | 22,913 | 21.13 | 484,128 |
2024-01-08 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 22,913 | 3.26 | 74,696 |
2024-01-06 | Pine Michael Craig (Chief Corp Dev.&Strat. Officer) | Option Ex | 15,285 | .00 | 0 |
2024-01-06 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 15,285 | .00 | 0 |
2024-01-06 | Duker Jay S. (President and CEO) | Option Ex | 20,793 | .00 | 0 |
2024-01-06 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 15,285 | .00 | 0 |
2024-01-06 | Lurker Nancy (Executive Vice Chair) | Option Ex | 75,133 | .00 | 0 |
2024-01-06 | Elston George (Chief Financial Officer) | Option Ex | 15,285 | .00 | 0 |
2023-12-13 | Paggiarino Dario A. (Chief Medical Officer) | Sale | 1,458 | 20.00 | 29,160 |
2023-12-13 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 1,458 | 10.13 | 14,769 |
2023-12-08 | Cormorant Global Healthcare Master Fund, Lp | Buy | 588,235 | 17.00 | 9,999,995 |
2023-12-06 | Liu Ye | Sale | 266,242 | 18.41 | 4,901,515 |
2023-12-06 | Ocumension Therapeutics (Director) | Sale | 266,242 | 18.41 | 4,901,515 |
2023-12-05 | Liu Ye | Sale | 733,758 | 19.91 | 14,609,121 |
2023-12-05 | Ocumension Therapeutics (Director) | Sale | 733,758 | 19.91 | 14,609,121 |
2023-12-04 | Pine Michael Craig (Chief Corp Dev.&Strat. Officer) | Sale | 45,000 | 22.00 | 990,000 |
2023-12-04 | Pine Michael Craig (Chief Corp Dev.&Strat. Officer) | Option Ex | 45,000 | 12.62 | 567,900 |
2023-12-04 | Cormorant Global Healthcare Master Fund, Lp | Buy | 1,919,057 | 26.82 | 51,465,270 |
2023-12-04 | Paggiarino Dario A. (Chief Medical Officer) | Sale | 30,625 | 22.00 | 673,750 |
2023-12-04 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 30,625 | 10.13 | 310,231 |
2023-12-04 | Lurker Nancy (Executive Vice Chair) | Sale | 20,000 | 20.76 | 415,200 |
2023-08-31 | Essex Woodlands Ix, Llc (10% Owner) | Sale | 78,495 | 10.59 | 831,576 |
2023-08-30 | Essex Woodlands Ix, Llc (10% Owner) | Sale | 60,976 | 11.14 | 679,333 |
2023-08-29 | Essex Woodlands Ix, Llc (10% Owner) | Sale | 87,854 | 11.15 | 979,659 |
2023-08-28 | Essex Woodlands Ix, Llc (10% Owner) | Sale | 60,858 | 11.71 | 712,647 |
2023-08-25 | Essex Woodlands Ix, Llc | Sale | 84,656 | 10.93 | 925,120 |
2023-08-24 | Essex Woodlands Ix, Llc | Sale | 139,280 | 14.62 | 2,036,134 |
2023-08-23 | Essex Woodlands Ix, Llc (10% Owner) | Sale | 121,103 | 13.05 | 1,580,878 |
2023-08-22 | Essex Woodlands Ix, Llc (10% Owner) | Sale | 46,778 | 14.62 | 683,847 |
2023-07-11 | Zaderej Karen L. | Option Ex | 2,000 | .00 | 0 |
2023-06-23 | Adamis Anthony P | Option Ex | 2,000 | .00 | 0 |
2023-05-30 | Liu Ye | Sale | 1 | 6.00 | 6 |
2023-02-09 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 9,967 | .00 | 0 |
2023-02-09 | Duker Jay S. (President and COO) | Option Ex | 11,967 | .00 | 0 |
2023-02-09 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 10,800 | .00 | 0 |
2023-02-09 | Landis John B. | Option Ex | 3,000 | .00 | 0 |
2023-02-09 | Lurker Nancy (CEO) | Option Ex | 37,533 | .00 | 0 |
2023-02-09 | Elston George (Chief Financial Officer) | Option Ex | 10,800 | .00 | 0 |
2023-02-09 | Guyer David R | Option Ex | 3,000 | .00 | 0 |
2023-02-09 | Dicicco Wendy F | Option Ex | 3,000 | .00 | 0 |
2023-02-09 | Ando Goran | Option Ex | 3,250 | .00 | 0 |
2022-11-01 | Duker Jay S. (Chief Operating Officer) | Option Ex | 15,258 | .00 | 0 |
2022-03-14 | Pine Michael Craig (Chief Corp Dev.&Strat. Officer) | Buy | 1,000 | 12.21 | 12,210 |
2022-02-28 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 4,105 | .00 | 0 |
2022-02-28 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 4,105 | .00 | 0 |
2022-02-28 | Lurker Nancy (President & CEO) | Option Ex | 12,466 | .00 | 0 |
2022-02-21 | Lurker Nancy (President & CEO) | Option Ex | 13,717 | .00 | 0 |
2022-02-09 | Landis John B. | Option Ex | 2,500 | .00 | 0 |
2022-02-09 | Dicicco Wendy F | Option Ex | 2,500 | .00 | 0 |
2022-02-09 | Ando Goran | Option Ex | 2,750 | .00 | 0 |
2021-11-15 | Lurker Nancy (President & CEO) | Sale | 10,000 | 20.15 | 201,480 |
2021-06-14 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 1,420 | .00 | 0 |
2021-02-28 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 4,105 | .00 | 0 |
2021-02-28 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 4,105 | .00 | 0 |
2021-02-28 | Landis John B. | Option Ex | 1,900 | .00 | 0 |
2021-02-28 | Lurker Nancy (President & CEO) | Option Ex | 12,467 | .00 | 0 |
2021-02-28 | Godshall Douglas Evan | Option Ex | 1,900 | .00 | 0 |
2021-02-28 | Guyer David R | Option Ex | 1,900 | .00 | 0 |
2021-02-28 | Dicicco Wendy F | Option Ex | 1,900 | .00 | 0 |
2021-02-28 | Ando Goran | Option Ex | 2,150 | .00 | 0 |
2021-02-21 | Lurker Nancy (President & CEO) | Option Ex | 13,717 | .00 | 0 |
2020-09-04 | Elston George (Chief Financial Officer) | Buy | 10,000 | .48 | 4,800 |
2020-08-24 | Elston George (Chief Financial Officer) | Buy | 10,000 | .61 | 6,110 |
2020-06-30 | Jones David Scott (SVP & Chief Commercial Officer) | Option Ex | 41,050 | .00 | 0 |
2020-06-30 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 41,050 | .00 | 0 |
2020-06-30 | Lurker Nancy (President & CEO) | Option Ex | 124,667 | .00 | 0 |
2020-06-27 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 10,000 | .00 | 0 |
2020-06-27 | Lurker Nancy (President & CEO) | Option Ex | 40,000 | .00 | 0 |
2020-06-14 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 14,200 | .00 | 0 |
2020-06-14 | Lurker Nancy (President & CEO) | Option Ex | 45,000 | .00 | 0 |
2020-03-12 | Elston George (Chief Financial Officer) | Buy | 10,000 | .96 | 9,600 |
2020-03-10 | Lurker Nancy (President & CEO) | Buy | 98,000 | 1.06 | 104,076 |
2020-02-21 | Lurker Nancy (President & CEO) | Option Ex | 137,174 | .00 | 0 |
2019-11-15 | Elston George (Chief Financial Officer) | Buy | 10,000 | 1.43 | 14,290 |
2019-10-09 | Mazzo David J | Option Ex | 33,333 | 1.95 | 64,999 |
2019-09-06 | Mazzo David J | Option Ex | 417 | .00 | 0 |
2019-06-27 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 10,000 | .00 | 0 |
2019-06-27 | Ross Leonard S (See Remarks) | Option Ex | 6,667 | .00 | 0 |
2019-06-27 | Lurker Nancy (President & CEO) | Option Ex | 40,000 | .00 | 0 |
2019-06-21 | Duker Jay S. | Option Ex | 6,667 | .00 | 0 |
2019-06-21 | Peterson Kristine | Option Ex | 6,667 | .00 | 0 |
2019-06-21 | Godshall Douglas Evan | Option Ex | 6,667 | .00 | 0 |
2019-06-21 | Mazzo David J | Option Ex | 8,333 | .00 | 0 |
2019-06-21 | Rogers Michael W | Option Ex | 6,667 | .00 | 0 |
2019-06-14 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 14,200 | .00 | 0 |
2019-06-14 | Ross Leonard S (See Remarks) | Option Ex | 8,280 | .00 | 0 |
2019-06-14 | Lurker Nancy (President & CEO) | Option Ex | 45,000 | .00 | 0 |
2019-05-13 | Landis John B. | Buy | 40,000 | 1.74 | 69,600 |
2019-04-12 | Duker Jay S. | Option Ex | 20,000 | 1.77 | 35,400 |
2019-04-01 | Duker Jay S. | Buy | 5,000 | 1.89 | 9,450 |
2019-04-01 | Ross Leonard S (See Remarks) | Option Ex | 5,000 | 1.81 | 9,050 |
2019-03-29 | Lurker Nancy (President & CEO) | Buy | 28,500 | 1.76 | 50,245 |
2019-03-29 | Godshall Douglas Evan | Buy | 17,000 | 1.75 | 29,784 |
2019-03-29 | Mazzo David J | Option Ex | 20,000 | 1.77 | 35,400 |
2018-12-22 | Ross Leonard S (See Remarks) | Option Ex | 62,892 | .00 | 0 |
2018-11-15 | Rogers Michael W (Director) | Option Ex | 100,000 | 1.13 | 112,999 |
2018-06-27 | Duker Jay S. (Director) | Option Ex | 12,500 | .00 | 0 |
2018-06-27 | Paggiarino Dario A. (Chief Medical Officer) | Option Ex | 10,000 | .00 | 0 |
2018-06-27 | Ross Leonard S (See Remarks) | Option Ex | 6,666 | .00 | 0 |
2018-06-27 | Lurker Nancy (President & CEO) | Option Ex | 40,000 | .00 | 0 |
2018-06-27 | Godshall Douglas Evan (Director) | Option Ex | 12,500 | .00 | 0 |
2018-06-27 | Mazzo David J (Director) | Option Ex | 17,500 | .00 | 0 |
2018-06-27 | Rogers Michael W (Director) | Option Ex | 12,500 | .00 | 0 |
2018-06-25 | Essex Woodlands Ix, Llc (10% Owner) | Buy | 16,864,066 | 1.26 | 21,333,043 |
2018-05-07 | Barry James J (Director) | Option Ex | 12,500 | .00 | 0 |
2018-04-20 | Mazzo David J (Director) | Option Ex | 120,000 | 1.13 | 135,600 |
2018-03-28 | Essex Woodlands Ix, Llc (10% Owner) | Buy | 8,606,324 | 1.10 | 9,466,956 |
2017-06-14 | Lurker Nancy (President and CEO) | Buy | 56,700 | 1.76 | 99,962 |
2016-03-18 | Ashton Paul (President & CEO) | Option Ex | 10,000 | 1.13 | 11,299 |
2016-01-04 | Ross Leonard S (Vice President, Finance) | Sale | 5,000 | 4.70 | 23,500 |
2016-01-04 | Ross Leonard S (Vice President, Finance) | Option Ex | 5,000 | 1.81 | 9,050 |
2015-12-22 | Ross Leonard S (Vice President, Finance) | Sale | 33,950 | 5.39 | 182,990 |
2015-12-22 | Ross Leonard S (Vice President, Finance) | Option Ex | 33,950 | 1.81 | 61,449 |
2015-12-22 | Ashton Paul (President & CEO) | Sale | 120,000 | 5.39 | 646,800 |
2015-12-22 | Ashton Paul (President & CEO) | Option Ex | 120,000 | 1.13 | 135,600 |
2015-12-01 | Ross Leonard S (Vice President, Finance) | Sale | 1,050 | 4.06 | 4,263 |
2015-12-01 | Ross Leonard S (Vice President, Finance) | Option Ex | 1,050 | 1.81 | 1,900 |
2015-08-03 | Ross Leonard S (Vice President, Finance) | Sale | 5,000 | 4.05 | 20,250 |
2015-08-03 | Ross Leonard S (Vice President, Finance) | Option Ex | 5,000 | 1.81 | 9,050 |
Insider trading activities including stock purchases, stock sales, and option exercises of EYPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eyepoint Pharmaceuticals, Inc. (symbol EYPT, CIK number 1314102) see the Securities and Exchange Commission (SEC) website.